Skip to search formSkip to main contentSkip to account menu

LSL 60101

Known as: LSL-60101 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

BenzofuransImidazoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Exploring the antidepressant-like potential of the selective I2-imidazoline receptor ligand LSL 60101 in adult male rats
While the alteration of I2 receptors has been associated with neurodegenerative and psychiatric disorders, among other brain… 
Highly Cited
2005
Highly Cited
2005
High-affinity binding of beta-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain.
2000
2000
Induction of reactive astrocytosis and prevention of motoneuron cell death by the I2‐imidazoline receptor ligand LSL 60101
I2‐imidazoline receptors are mainly expressed on glial cells in the rat brain. This study was designed to test the effect of… 
Review
1999
Review
1999
Pharmacologic Characterization of Imidazoline Receptor Proteins Identified by Immunologic Techniques and Other Methods a
ABSTRACT: Biochemical and pharmacologic evidence supports the heterogeneous nature of imidazoline receptors (IRs). However, only… 
Highly Cited
1998
Highly Cited
1998
Attenuation of tolerance to opioid‐induced antinociception and protection against morphine‐induced decrease of neurofilament proteins by idazoxan and other I2‐imidazoline ligands
1 Agmatine, the proposed endogenous ligand for imidazoline receptors, has been shown to attenuate tolerance to morphine‐induced… 
1996
1996
Pharmacological modulation of immunoreactive imidazoline receptor proteins in rat brain: relationship with non‐adrenoceptor [3H]‐idazoxan binding sites
1 The densities of various imidazoline receptor proteins (with apparent molecular masses of ≅29/30 −45‐ and 66‐kDa) were… 
1995
1995
LSL 60101, a selective ligand for imidazoline I2 receptors, on glial fibrillary acidic protein concentration.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)